Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fady T. Botros
Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program
Diabetes/Metabolism Research and Reviews
Internal Medicine
Endocrinology
Metabolism
Diabetes
Collecting Duct Renin Is Upregulated in Both Kidneys of 2-Kidney, 1-Clip Goldblatt Hypertensive Rats
Hypertension
Internal Medicine
Related publications
Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Dulaglutide – New in the Treatment of Type 2 Diabetes
Effective Pharmacotherapy
Dulaglutide Slows Kidney Disease in Type 2 Diabetes
The Lancet
Medicine
A 1-Year Safety Study of Dulaglutide in Japanese Patients With Type 2 Diabetes on a Single Oral Hypoglycemic Agent: An Open-Label, Nonrandomized, Phase 3 Trial
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes
Pharmacy Today
Dulaglutide Slows Kidney Disease in Type 2 Diabetes − Author's Reply
The Lancet
Medicine
The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients With Type 2 Diabetes Mellitus in Taiwan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Diabetes Prevention Program. Design and Methods for a Clinical Trial in the Prevention of Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes
American Journal of Cardiology
Cardiovascular Medicine
Cardiology